Beryl Drugs informs about unaudited quarterly financial results

11 Aug 2021 Evaluate

Pursuant to Regulation 30 read with Part-A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Beryl Drugs has informed that the Board of Directors in its 35th Board Meeting held on 11.08.2021 has approved the Unaudited Financial Results of the Company for the Quarter ended 30.06.2021.

The above information is a part of company’s filings submitted to BSE.

Beryl Drugs Share Price

35.20 -0.13 (-0.37%)
19-Apr-2024 11:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1509.40
Dr. Reddys Lab 5915.35
Cipla 1353.70
Zydus Lifesciences 920.30
Lupin 1565.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.